In CAR T cell-treated lymphomas, the T cell rich get richer

Theodora Anagnostou; Joshua D. Brody

doi:10.1038/s41591-022-01922-z

In CAR T cell-treated lymphomas, the T cell rich get richer

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	1757-1758
Number of pages	2
Journal	Nature Medicine
Volume	28
Issue number	9
DOIs	https://doi.org/10.1038/s41591-022-01922-z
State	Published - Sep 2022

Access to Document

10.1038/s41591-022-01922-z

Cite this

@article{1acafa5f9a464d528f9fd20642ff9fda,

title = "In CAR T cell-treated lymphomas, the T cell rich get richer",

author = "Theodora Anagnostou and Brody, {Joshua D.}",

note = "Funding Information: J.D.B. receives research funding or non-financial support from: Merck, Genentech, Kite/Gilead, SeaGen, Astrazeneca, ADC Therapeutics, Epizyme, Celldex Therapeutics and Oncovir.",

year = "2022",

month = sep,

doi = "10.1038/s41591-022-01922-z",

language = "English",

volume = "28",

pages = "1757--1758",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "9",

}

TY - JOUR

T1 - In CAR T cell-treated lymphomas, the T cell rich get richer

AU - Anagnostou, Theodora

AU - Brody, Joshua D.

N1 - Funding Information: J.D.B. receives research funding or non-financial support from: Merck, Genentech, Kite/Gilead, SeaGen, Astrazeneca, ADC Therapeutics, Epizyme, Celldex Therapeutics and Oncovir.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85137255469&partnerID=8YFLogxK

U2 - 10.1038/s41591-022-01922-z

DO - 10.1038/s41591-022-01922-z

M3 - Article

C2 - 36038630

AN - SCOPUS:85137255469

SN - 1078-8956

VL - 28

SP - 1757

EP - 1758

JO - Nature Medicine

JF - Nature Medicine

IS - 9

ER -